Pfizer clinical trials show that their vaccine is safe and produces a strong immune response in 5-11 YOs. Two dose, with 1/3 of the mRNA of adult dose. They'll be applying for FDA approval. They're also trialling 1/10th adult dose for 1-5 YOs.
This on top of FDA being likely to approve boosters for over 65 or vulnerable in the next couple of days is good. Children are now a significant vector for delta in the US. While only a few tens of thousands have been hospitalized, they're a disproportionately high % of new cases
Great news. Hopefully Medsafe & cabinet can really expedite their analysis of this one, and not spend 4 months on it like the 12-15 age group...
Sounds like the F.D.A. has asked for an expanded trial so rare side effects can be better analysed, but it likely to give it the green light in the meantime while that data comes in.